KRBP

Kiromic BioPharma, Inc.

1.51 USD
-1.95 (-56.36%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kiromic BioPharma, Inc. stock is up 0.67% since 30 days ago. The next earnings date is Apr 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January.

About Kiromic BioPharma, Inc.

Kiromic BioPharma focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc.; and Longwood University.